2
From nexium to generics: a young RUDN scientist has proposed a way to reduce the cost of pediatric reflux treatment

From nexium to generics: a young RUDN scientist has proposed a way to reduce the cost of pediatric reflux treatment

XXXII Russian National Congress “Man and Medicine” was held in Moscow, a key event for the medical and pharmaceutical community. Pavel Murzov, an assistant professor at the Department of Pharmacy Management and Economics at RUDN University, became the winner among thousands of participants. He presented a study on the rational use of Proton Pump Inhibitors (PPIs) in pediatrics.

How does reflux esophagitis manifest?

Symptoms include frequent episodes of heartburn and discomfort behind the sternum, regular belching with sour taste, abdominal and chest pain, decreased appetite, sleep disorders, and excessive moodiness. The lack of timely treatment can provoke the development of erosive lesions and ulcers of the esophageal mucosa, cicatricial stricture (narrowing of the lumen of the esophagus), which will cause obstacles to the normal passage of food. Also, advanced reflux esophagitis increases the likelihood of esophageal cancer. PPIs are mainly used for treatment. These are effective but expensive drugs. The high price is associated with the complexity of the synthesis of active substances — they have a complex chemical structure, and some components are active only under strictly defined pH conditions. Rising equipment and infrastructure costs, research and development costs, improvements to existing formulas, as well as royalties and patenting factors are also affected.

“We analyzed 1,508 appointments for children under the age of 17. The data included the Moscow region and the pharmaceutical market (pharmacies and e-pharmacies). As a result, 83.7% of prescriptions were for the original Nexium drug and 61% for generics. The range in the price of drugs ranges from 44 to 5089 rubles. To optimize the cost of treatment with proton pump inhibitors (PPIs) in pediatrics, while maintaining high efficiency, it was proposed to use generics — they are significantly cheaper than the original drugs and retain a comparable effect. It is also worth rationalizing dosages — for example, starting therapy with the lowest effective dose and then gradually increasing it if the result is insufficient. This way you can reduce the consumption of an expensive drug and minimize side effects,” Pavel Murzov, Assistant at the Department of Pharmacy Management and Economics at RUDN University.

Which PPIs from the list of vital medicines are most beneficial for healthcare system?

Omeprazole:

  • Effective and widely used in pediatrics.
  • It has a convenient release form (capsules, suspension).
  • Moderate cost, suitable for preferential provision.
  • Esomeprazole (Nexium):
  • A more modern analogue of omeprazole with similar efficacy.
  • High degree of evidence regarding efficacy and safety.
  • May have a high cost, but it is offset by better tolerability of medication.

“My research focuses on the rational use of medicines in pediatrics. In addition to studying proton pump inhibitors (PPIs), we plan to consider similar problems with other important groups of medicines, such as antibiotics, antihistamines, immunostimulants, and anti—inflammatory drugs,” Pavel Murzov.

Visiting Professors View all
12 Dec 2024
In 2024, RUDN started accepting applications for the new annual Prize for Scientific Achievement in Chemistry. The award was established to honour contributions to fundamental and applied research, as well as merit in achieving the UN Sustainable Development Goals.
1214
Research and Innovative Activity View all
30 Dec 2020
In 2017, RUDN University scientists constructed a new explicit second-order precision difference scheme using modern computer algebra methods for 2-dimensional Navier-Stokes equations (NSE) [1]. This year, our mathematicians used a new scheme [2] to construct a numerical solution to the Cauchy problem with initial data (for t=0) as satisfying the continuity equation. Scientists managed to achieve previously unattainable accuracy of the continuity equation.
2365
Similar newsletter View all
21 Apr
The legacy of Academician Paltsev: RUDN University hosted the first conference on the functional morphology of the tissue microenvironment

The first research and practical conference ‘Functional Morphology of the Tissue Microenvironment: From Theory to Practice’, dedicated to the memory of Academician Mikhail Paltsev of the Russian Academy of Sciences, was held at RUDN. It brought together leading researchers from Russia, China and other countries.

58
21 Apr
The sixth GreenTech Sustainable Development Acceleration Program starts accepting applications

The Skolkovo Foundation (VEB.RF), together with the Ministry of Natural Resources and Environment of the Russian Federation and the country’s leading industrial companies, announced the launch of the sixth cycle of Russia’s largest supplier ecosystem development program for industry, GreenTech Sustainable Development. Applications from developers of technological solutions will be accepted until October 20, 2025.

49
21 Apr
Surgery, science, lasers: a report by a RUDN University student won a competition at the conference “Clinical Laser Medicine in Russia: Advanced Technologies”

In November, RUDN University hosted the country's first scientific and practical conference, “Clinical Laser Medicine in Russia: Advanced Technologies”. The event brought together specialists from various fields of medicine and biophotonics. It was attended by more than 300 scientists, researchers, and practicing doctors of various specialties from Russia and 32 foreign countries involved in laser technologies, as well as over 650 representatives of the younger generation—students, interns, graduate students, and young scientists.

51
Similar newsletter View all